COPENHAGEN, September 24, 2012 /PRNewswire/ --
Agnitio, a leader in closed-loop marketing technology, has recently secured partnerships with three major, international companies in the healthcare sector, enabling them to communicate with their customers in a more personalised and targeted way.
In providing its products and services to over 5,000 new users, the agreements cover a range of the company's offerings including iPlanner (iPad), iPlanner Light and Viewer (iPad), iDocs, Agnitio Manager and Agnitio Analyzer. As well as providing its software platform to the three new partners, Agnitio will also work closely with them on the deployment and support of the system.
"These are important new partnerships for us and show the faith that international companies have in both our products and our expertise, which allow them to communicate far more effectively with their customers in an increasingly competitive market," says Morten Hjelmsoe, CEO and Founder of Agnitio. "Agnitio continues to go from strength to strength as we expand our footprint beyond Europe and the United States to be truly global."
Head quartered in Denmark, with offices in the UK, Germany, France, Brazil and the United States, Agnitio is responsible for the leading pull marketing software platform for the pharmaceutical and medical device industries. Working for major firms including GSK, Novartis and Bayer, Agnitio helps generate effective relationships with medical professionals via its platform. Through understanding doctors' individual needs and interests, highly relevant and precisely targeted information and services can be provided quickly and easily.
Agnitio helps pharmaceutical and medical device companies generate effective relationships with medical professionals. The provider of the leading pull marketing software platform for the pharmaceutical and medical device industries, Agnitio's system is already implemented in more than 45 countries and 25 languages - and used by major pharmaceutical and medical device companies including: GSK, MSD, Novartis, Roche and Bayer.
For further information please contact:
Julien Cozens, Madano Partnership:
Tel + 44-7867-998222 or + 44(0)207-593-4000